RHJA
CELG

Rice Hall James & Associates’s Celgene Corp CELG Stock Holding History

Rice Hall James & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,500
Closed -$270K – 337
2015
Q3 		$270K Hold
2,500
– – 0.02% 284
2015
Q2 		$289K Sell
2,500
-4,500
-64% -$514K 0.02% 290
2015
Q1 		$807K Sell
7,000
-4,000
-36% -$478K 0.05% 258
2014
Q4 		$1.23M Hold
11,000
– – 0.07% 233
2014
Q3 		$1.04M Hold
11,000
– – 0.07% 233
2014
Q2 		$945K Hold
11,000
– – 0.06% 234
2014
Q1 		$768K Hold
11,000
– – 0.06% 240
2013
Q4 		$929K Hold
11,000
– – 0.07% 224
2013
Q3 		$848K Hold
11,000
– – 0.08% 192
2013
Q2 		$643K Buy
+11,000
New +$662K 0.06% 206

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Rice Hall James & Associates's CELG Position: Q4 2015 in Review

Rice Hall James & Associates sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 2,500 shares — an estimated $270K sold.

Rice Hall James & Associates first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $1.23M in Q4 2014. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Rice Hall James & Associates reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • Rice Hall James & Associates sold 2,500 Celgene Corp shares in Q4 2015, an estimated $270K.
  • Rice Hall James & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • Rice Hall James & Associates's Celgene Corp position peaked at $1.23M in Q4 2014.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.